Lupus & antiphospholipid syndrome

Single-cell profiling reveals kidney CD163+ dendritic cell participation in human lupus nephritis

Ann Rheum DisPublished Mechanistic study

Authors' conclusion

The intricate interplay involving DC3s, T cells and tubular epithelial cells within kidneys may substantially contribute to LN pathogenesis.

Study context

Population
Patients with LN undergoing renal biopsy and healthy donors; matched peripheral blood from 7 LN patients; independent cohort of 60 patientsindependent cohort of 60 patients
Participants
40 vs 6
Comparison
LN kidneys vs healthy donor kidneys
  • LNn = 40
  • Healthy donorsn = 6reference
Methodological detailssingle-cell RNA and T cell receptor sequencing, multiplex immunohistochemistry, flow cytometry, in vitro assays, independent validation cohort
  • Single-cell RNA and T cell receptor sequencing
  • Multiplex immunohistochemistry
  • Flow cytometry
  • In vitro assays
  • Independent validation cohort

Main finding

As reported in the abstract

  • Notable enrichment of CD163+ dendritic cells (DC3s) in LN kidneys, positively correlated with LN severity
  • Kidney DC3s in LN displayed activated, highly proinflammatory phenotype vs blood counterparts
  • DC3s interacted strongly with CD4+ T cells, contributing to intrarenal T cell clonal expansion, CD4+ effector T cell activation and Th1/Th17 polarisation
  • Injured proximal tubular epithelial cells (iPTECs) may orchestrate DC3 activation, adhesion and recruitment in LN kidneys
  • In culture, blood DC3s treated with iPTECs acquired distinct capabilities to polarise Th1/Th17 cells
  • Kidney DC3 enumeration might be a potential biomarker for induction treatment response in LN

Original publication

Single-cell profiling reveals kidney CD163+ dendritic cell participation in human lupus nephritis. Ann Rheum Dis. Published 11 April 2024. doi:10.1136/ard-2023-224788

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.